Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Liraglutide (Victoza®) injection (GLP1s should all be prescribed by brand name)	NICE NG28: Type 2 diabetes in adults - management	THIS IS FOR DIABETES ONLY. Prescribe by brand (Victoza®) to avoid patients inadvertently receiving a different product licensed for obesity. 1.8 mg is non-formulary.
Lisinopril tablets
Lixisenatide (Lyxumia®)		1st line choice GLP1 for co-prescribing with insulin. RICaD.
Lizinna		Umbrella service only
Lofepramine suspension		Specialist initiation only
Lofepramine tablets		Specialist initiation only
Loperamide capsules		Capsules are more cost effective than tablets
Loperamide instant melts®		Restricted to high output stoma patients
Loratidine
Lorazepam tablets

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.